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ABSTRACT 
Wasting has been observed as a common feature of the human immunodeficiency virus (HIV) disease since the first 
reports and its presence increases the risk of death. There is no consensus on how to manage wasting associated with 
HIV. The goal of this study was to assess the effectiveness of a locally made Chickpea Sesame Based RUTF (CS-RUTF) 
in treating wasting associated with HIV in developing countries. Chronically sick adults from Mangochi Health District 
(Malawi) with wasting and confirmed or presumptive clinical diagnosis of HIV were recruited for the study. Subjects 
received a daily ration of 500 grams of CS-RUTF for 3 to 5 months. Nutrition status changes and mortality were used 
to assess the effectiveness of the intervention. There were 3 patterns of anthropometric responses continuous weight 
gain (WG), static weight (SW) and continuation weight loss (WL). The distribution of the 3 patterns is 53.9% (82/154) 
for the WG pattern, 9.1% (14/154) for the SW pattern and 37.0% (57/154) for the WL pattern. For the WG pattern, the 
overall median weight gain was 4.6 (2.4 to 7.1) kg. It was 5.7 (3.5 to 7.8) kg for those who completed 3 months of sup- 
plementation. MUAC and BMI changes followed similar pattern than weight change. Not being on HAART, acute diar- 
rhoea during follow up, episode of reduced appetite during follow up, missing at least one visit were identified as risk 
factors for intervention failure. Overall, 38.5% (72/187) of study participants died during the intervention. In conclu- 
sion, despite that the study confirms the limited impact of food based interventions on mortality among wasted HIV pos-
itive individuals, it also suggests that supplementation with CS-RUTF may be an effective intervention for reversing 
wasting associated with HIV if combined with HAART and specific treatment of severe opportunistic infection causing 
diarrhoea and reducing appetite. 
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1. Introduction 
HIV/AIDS is not just a public health problem but it is a 
major developmental concern of the century [1-5]. The 
pandemic has reduced the size and productivity of the 
workforce as a result of excess mortality, prolonged ill- 
ness that causes frequent absenteeism and a reduced 
working capacity [4,6-8]. Wasting, defined convention- 
ally as the involuntary loss of 10% or more of one’s 
premorbid weight, contributes to this situation through an 
association with fatigue and an increased risk of death 
[9-12].  
Wasting has been observed as a feature of HIV disease 
since the first reports of the condition [13,14]. In indus- 
trialized countries, the prevalence of wasting in People 
Living with HIV (PLHIV) varies between 17 percent and 
50% [15-18]. In developing countries, this prevalence is 
difficult to determine as premorbid weight is rarely 
known, however, studies using the criteria Body Mass 
Index (BMI) < 18.5 kg/m2 or MUAC < 22.0 cm for 
women and <23.0 cm for men, have demonstrated a 
prevalence at the time of commencing HAART of up to 
25% [12,19-22]. This is almost certainly an underestima-
tion of the true prevalence of wasting as many more 
PLHIV loose more than 10% of their premorbid weight 
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without meeting the BMI or MUAC criteria mentioned 
above.  
There is now good evidence to confirm that the pres- 
ence of wasting is associated with increasing risk of 
mortality in PLHIV [11,12,16,19,23-25]. In the pre- 
HAART era, studies conducted in high-income countries 
showed that wasting was associated to up to 13.7% of 
death with individuals with moderate to severe wasting 
having 1.9 and 6.7 more risk of dying within the year, 
respectively [25,26]. Similar results have been reported 
in West Africa where Van der Sande et al. noted that the 
baseline BMI recorded within three months of the diag- 
nosis of HIV infection is a strong and independent pre- 
dictor of mortality and the predictive power was as good 
as that of CD4 cell count [19]. In their study, patients 
with a BMI below 16 were 6.4 times more likely to die 
than individuals with a BMI above 22 kg/m2 and those 
with BMI below 18 kg/m2 were 3.4 times more likely to 
die than those with a BMI above 18 kg/m2 [19]. Studies 
have shown that even after the advent of  Highly Active 
AntiRetroviral Therapy (HAART), the mortality among 
PLHIV with wasting at the time of commencing HAART 
remain high [11,12,21]. In a retrospective study evaluat- 
ing the outcomes of patients on HAART in Singapore, 
Paton et al found that BMI < 17 was a strong independ- 
ent predictor of death with an adjusted hazard ratio of 2.2 
[11]. A study in Malawi also found that patients with 
BMI < 16, 16 to 16.9 and 17 to 18.4 had, after adjust- 
ment for confounding, a 6.0, 2.4 and 2.1 fold higher risk 
of dying respectively within the first 3 months of 
HAART treatment than those who had a BMI ≥ 18.5 
kg/m2 at HAART commencement [12]. Similar results 
have been reported for many other developing countries 
including Burkina Faso, Tanzania and Zambia [21, 
27-31].  
At present there is no consensus on how to manage 
PLHIV with wasting or other forms of malnutrition [32]. 
Various studies have examined nutritional interventions 
in the form of oral supplementation or total parenteral 
nutrition and many of these studies have reported persis- 
tence of high mortality in wasted adults receiving nutri- 
tion supplementation in combination or not with HAART 
[23,32-34]. The most popular nutrition supplement used 
in resource-poor countries to combat wasting in PLHIV 
is corn soya blend mixed with vegetable oil. The first 
scientific evaluation on the impact of this intervention 
was conducted in Malawi within the Bangwe home based 
care programme, indicated that it had a limited impact on 
the nutritional status and the survival of PLHIV admitted 
in the programme with advanced HIV [23]. In contrast to 
the Bangwe findings, anecdotal results obtained with the 
Ready to Use Therapeutic Food (RUTF) in Malawi in 
children as well as in adults were encouraging [35-37]. 
Up to 59% of HIV positive malnourished children treated 
in Dowa community-based Therapeutic Care (CTC) pro- 
gramme, recovered with RUTF alone in absence of 
HAART. The majority of those who recovered retained a 
good nutritional status after an average 15.5 months after 
discharge from the programme [35]. A pilot programme 
conducted by Valid International has also shown that 
RUTF can be used to treat malnutrition in chronically 
sick adults at home through home based care programme 
structures [36]. In this programme, 54% of bedridden 
adults improved their physical activity by at least one 
grade in the Karnofsky score within the first 2 weeks of 
the treatment; this was accompanied with improvements 
in nutritional status [36]. The goal of the study was to 
confirm the findings of the pilot study and identify fac- 
tors affecting the effectiveness of therapeutic feeding 
with RUTF and describe its benefits on a larger study 
group. This paper reports on the impact of the therapeutic 
feeding intervention on nutrition parameters, including 
anthropometric parameters, haemoglobin, physical activ- 
ity performance measured by the Karnofsky score and 
the handgrip, and body composition.  
2. Methods 
2.1. Setting 
The study was implemented in the Mangochi Health Dis- 
trict, Malawi, between October 2006 and May 2007. 
Mangochi lies at the southern tip of Lake Malawi. The 
district had a population of around 778,338 in 2007. Al- 
though fishing is the main income generating activity of 
the district, subsistence farming employs 90% of the 
population. The estimated prevalence of HIV in the dis- 
trict was 21% in 2007. In the district, stigmatization is a 
major barrier to access health care. As a consequence 
both HIV testing and enrolment HAART programme are 
often delayed and the compliance poor. Reasons cited for 
this include fear of stigmatization, cost of transport and 
food insecurity. Save the Children and ten Community 
Based Organisations (CBOs) work to support PLHIV and 
all the participants were recruited within their catch- 
ment’s areas. Free HAART was available in the area 
from government or mission hospital and one of the 10 
CBOs offered transportation to their clients from the 
CBO office to the HAART clinic. 
2.2. Study Design and Procedures 
Chronically sick adults were eligible for enrolment in the 
study if they met one of the following criteria: 1) living 
in the catchment area of a participating CBO; 2) con- 
firmed or presumptive clinical diagnosis of HIV and 3) 
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MUAC < 22.0 cm or BMI < 17 kg/m2 or confirmed 
weight loss > 10% or bilateral pitting oedema of the feet 
or legs. Exclusion criteria included diabetes, hypertension, 
known renal insufficiency, long term physical disability 
or inability to eat. 
The key interventions included 1) nutrition education 
and counselling to participants and their caregivers and 2) 
Nutrition Support with Chickpea Sesame Based RUTF 
(CS-RUTF) and 3) Medical support: including Cotri- 
moxazole prophylaxis and treatment for minor diseases, 
referral and linkage with nearest health facility for man- 
agement of severe medical conditions and the nearest 
HAART clinic for treatment.  
At admission, MUAC, weight, height, sitting height 
and presence of bilateral oedema were checked to con- 
firm nutrition status. Participants were classified as 
wasted if they had a MUAC < 22.0 cm for women and 
<23.0 cm for men or BMI < 18.5 kg/m2. They were clas- 
sified as severely wasted when BMI was <16 kg/m2 or 
MUAC < 18.5 kg/m2. 
The physical activity performance was measured using 
the Karnofsky scores and Eastern Cooperative Oncology 
Group (ECOG) score and handgrip. A brief medical his- 
tory and physical examination was conducted to deter- 
mine the clinical WHO HIV stage and identify existing 
morbidity. Blood was taken, to measure haemoglobin 
and CD4 count. The haemoglobin level was determined 
using a Hemacue haemoglobinometer (HeamaCue AB, 
Angelholm,Sweden) and participants with haemoglobin 
below 8 g/dl were classified as severely anaemic. Analy- 
ses for estimation of CD4 count were done using Fluo- 
rescence Activated Cell Sorter (FACS) count flow cy- 
tometer (Becton Dickinson, Singapore) at the University 
of North Carolina Project Laboratory in Lilongwe. 
Study participants were followed up at week 2, 
month1 and then monthly during the therapeutic feeding 
phase. After discharge from the therapeutic feeding 
phase, study participants were followed up quarterly 
during 12 months. Clinical and nutrition data were col- 
lected at each follow up. Additionally, information on 
CS-RUTF intake was collected during the therapeutic 
feeding phase. Calculation of CS-RUTF intake was 
based on self-reporting (total number of pots eaten and 
daily intake during the period under review). This infor- 
mation was completed by the counting of terminated 
empty pots. Household food security conditions and the 
intake of additional foods were assessed at admission and 
during follow up. The intake of additional foods was 
assessed on a 24-hour and a 7-day food intake recall ap- 
proach.  
Study participants were discharged from the therapeu- 
tic feeding phase if they reached the discharge criteria of 
MUAC > 23.0 cm (minimum and maximum stay in the 
programme of 12 and 20 weeks) or if they decided to 
abandon the study or if they moved out from the study 
catchment area of the study or if they died. For the fol- 
low up after therapeutic feeding phase, participants were 
censored if they completed the 12 months or if they 
moved out of the study area or if they died.  
For this study, the weight loss prior to admission was 
estimated using the mean weight of rural adults Mala- 
wian published by Zverev and Chisi. Nutrition status 
improvement was assed using both physical activity per- 
formance criteria and anthropometric criteria. The phy- 
sical activity performance criteria included improvement 
in Karnofsky score and increase in handgrip while the 
anthropometric criteria include weight, MUAC and BMI 
gains and achievement of the MUAC discharge criteria. 
We arbitrary defined static weight as a weight change ≤ 
500 g.  
2.3. Study Food 
The composition of the CS-RUTF has been previously 
published [36]. Subjects were recommended to consume 
two pots (500 g) providing 2600 kilocalories, 61.5 g of 
proteins and >1 RDI for all the vitamins and minerals per 
day. The aim was to provide the daily requirements but 
participants were allowed to eat other family food be- 
cause it was not suitable and impossible to impose a 
monotonic diet for 3 to 5 months  
2.4. Data Analyses and Statistics 
Data analyses were performed using SPSS 10.0 for 
Windows (SPSS Inc., Chicago, IL, USA). Quantitative 
data for normally distributed variables were described 
using means and standard deviation (SD) and compared 
using Student’s t-test for 2 group comparisons and 
ANOVA test for multiple group comparisons; non-nor- 
mally distributed variables were described using median 
and inter-quartile range (IQR) and compared using the 
Kruskall Wallis test. Dichotomous variables were com- 
pared using the Pearson or the McNemar χ2 test as ap- 
propriate. The associations between change in nutrition 
status and variables upon admission and follow up were 
explored using the bivariate analysis followed by a step- 
wise logistic regression. For the logistic regression 
analysis, all the methods (enter, forward and backward) 
were used to identify the potential independent predictors. 
The enter method was used for the final models that in- 
cluded all variables selected by each of the methods. 
Wald statistics were used to test the statistical signifi- 
cance of the variables retained in the final model. 
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2.5. Ethical Considerations 
The research protocol was submitted to the National 
Health Sciences Research Committee (NHSRC) and the 
NHSRC provided ethical approval under the number 407. 
Participation was voluntary. Before inclusion participants 
signed a consent form after receiving complete informa- 
tion on study objectives and procedures. The consent 
form that was in englesh and local language included the 
authorisation to participate into the study and of the pub- 
lication of findings. The participant had the right to with-
draw from the study at any time, during the study period. 
3. Results 
Characteristics of Participants and Their  
Households 
Overall, 194 individuals were enrolled into the study. 
Among them, 59.8% (116/194) had an HIV confirmed 
diagnosis. From the remaining, 7 later tested HIV nega- 
tive (Negative Eliza test and CD4 count between 645 and 
1464 cells/µl.) and the others were later confirmed 
HIV-infected. Based on the WHO clinical staging for 
HIV, almost all participants had clinical advanced AIDS. 
While 25.7% (48/187) had started HAART before en- 
rolment, 5.9% (11/187) started HAART during the 
therapeutic feeding phase. Table 1 shows that the major- 
ity of participants enrolled were female and young. More 
than a third had never attended school. 79.4% of the 
study participants had stopped working because of illness 
and more than 60% were bedridden (Karnofsky score < 
50%) and required considerable support in daily living 
activities. Almost one third of them described their own 
health condition as poor, very poor or terrible. Coping 
strategies for household food insecurity were common 
among participants: 93.0% (180/194) used certain coping 
strategies before enrolment. Only 2.6% of participants 
had eaten food from the 6 different food group the day  
 
Table 1. Socio-demographic profile and health condition of the participants at admission. 
 n % 
Sex   
Male 58 31.0 
Female 129 69.0 
Total 187 100.0 
Age   
Mean (SD) 34.1 (SD 9.2) 
<18 year 3 16 
18 - 49 years 164 88.2 
>49 years 19 10.2 
Total 186 100.0 
Schooling level   
Never attend school 65 34.8 
Complete or incomplete primary school 105 56.1 
Secondary school 12 6.4 
Missing data 5 2.7 
Total 187 100.0 
Working status   
Working 25 13.4 
Not working 155 82.9 
Missing data 7 3.7 
Total 187 100.0 
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Karnofsky score   
90: Able to perform normal activity; minor signs and symptoms of disease 7 3.7 
80: Able to perform normal activity with effort;some signs/symptoms of disease 19 10.2 
70: Cares for self, unable to perform normal activity or to do active work 81 43.3 
60: Requires occasional assistance but is able to care for most of own needs 31 16.6 
50: Requires considerable assistance and frequent medical care 31 16.6 
40: Requires special care and assistance; disabled 8 4.3 
30: Hospitalisation indicated although death not imminent; severely disabled 2 1.1 
20:Hospitalisation necessary, active supportive treatment required; very sick 5 2.7 
10: fatal processes progressing rapidly; moribong 1 0.5 
Data missing 2 1.1 
Total 187 100.0 
Self rating of health condition   
Good or Excellent 4 2.1 
Fair 93 49.7 
Poor 50 26.7 
Very poor or terrible 39 20.9 
Data missing 1 0.5 
Total 187 100.0 
HIV WHO clinical stage   
Stage 3 74 39.6 
Stage 4 113 60.4 
Total 187 100.0 
CD4 count (Cells/microliter)   
Median (IQR) 165 (IQR 85.5 - 348.0) 
<50 28 15.0 
50 - < 100 16 8.6 
100 - < 200 40 21.4 
200 - < 350 32 17.1 
>350 37 19.8 
Data missing 34 18.2 
Total 187 100.0 
Handgrip (kg)   
<19.3 74 39.6 
<19.3 113 60.4 
Total 187 100.0 
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before admission into the study. 
The nutrition status at admission is described in Table 
2. Of note, two third of the participants had an estimated 
weight loss greater than 10% and more than one third of 
participants were found to be severely wasted with some 
having also bilateral pitting oedema. The average hae- 
moglobin was very low and severe anaemia was ob- 
served in more than a third of the participants. At the 
time of enrolment, women had likely loss more weight 
than men [mean % (SD) weight loss 18.1 (10.8)% for 
women and 7.8 (13.4)% for men; p < 0.001]. Similarly, 
the estimated reduction in MUAC was more important in 
women [mean (SD) 2.6(0.7) cm for women and 1.6 (0.6) 
cm for men; p < 0.001] 
At admission, all the 187 participants accepted to eat 
RUTF after tasting it but 9 later stopped taking CS- 
RUTF giving an overall dropout rate of 4.8% (9/187). 
Self reported intake average (SD) was 255.3 (139.0) 
g/day corresponding to 32.1(19.2) kcal/kg/day.  
Anthropometric response to the therapeutic feeding 
could be calculated for 154 out of 187 participants who 
had at least one follow up visit. The overall median (IQR) 
of weight gain at discharge was 0.9 (−1.9 - 5.1)kg. It was 
2.8 (−1.7 - 6.6) kg for those who received the supplement 
for a minimum of 3 months. There were 3 patterns of 
anthropometric responses based on weight change namely 
continuous weight gain (WG), static weight (SW) and 
continuation of weight loss (WL). The distribution of the 
3 patterns is 53.9% (82/154) for the WG pattern, 9.1% 
(14/154) for the SW pattern and 37.0% (57/154) for the 
WL pattern. The mean (SD) of reported daily CS-RUTF 
intake per body weight was 36.2 (20.0) Kcal/kg/day for 
the WG pattern, 30.2 (18.7) Kcal/kg/day for the SW pat- 
tern and 29.6 (15.1) Kcal/kg/day for the WL pattern (p = 
0.104). The duration into the therapeutic phase was also 
not significantly different and was 99.4 (24.9) days fro 
the WG pattern, 108 (32.6) days for the SW pattern and 
91.9 (35.5) days for the WL pattern, respectively (p = 
0.135). The median (IQR) weight gain according to the 
anthropometric pattern response were 4.6 (2.4 to 7.1) kg 
for the WG pattern, −0.1 (−0.4 to 0.2) kg for SW pattern 
and −2.8 (−3.9 to −1.7) kg, for the WL pattern. Among 
those who remained in the programme for a minimum of 
3 months, the median (IQR) weight gain were 5.7 (3.5 to 
7.8) kg for WG pattern (n = 58), −0.4 (−0.5 to 0.0) kg for 
the SW pattern (n = 6) and −2.5 (−4.5 to −1.8) kg for WL 
pattern (n = 28). The changes in MUAC, BMI, and hand- 
grip for the different patterns are presented in Table 3. 
The differences in changes of MUAC, BMI and handgrip 
from admission to discharge were statistically significant. 
The difference was more important when only those who 
received the therapeutic food for at least 3 months were  
Table 2. Nutrition status at admission. 
Variable n % 
Estimated percentage weight loss   
Mean (SD) 15.9 (SD 12.8) 
≥10% 122 65.2 
5% -< 10% 27 14.4 
<5% 33 17.6 
Missing 5 2,7 
Total 187 100.0 
MUAC   
Mean (SD) 19.6 (SD 1.9) 
<16.0 7 3.7 
16.0 < 18.5 38 20.3 
18.5 < 22.0 127 67.9 
≥22.0 12 6.4 
Data missing 3 1.6 
Total 187 100.0 
BMI   
Mean (SD) 16.3 (SD 1.9) 
<16.0 68 36.4 
16.0 < 17.0 37 19.8 
17.0 < 18.5 51 27.3 
≥18.5 20 10.7 
Data missing 11 5.9 
Total 187 100.0 
Oedema   
Present 25 13.4 
Absent 162 86.6 
Total 187 100.0 
Hemoglobin (g/l)   
Mean (SD) 8.8 (SD 1.2) 
<8.0 61 32.6 
≥8.0 103 55.1 
Data missing 23 12.3 
Total 187 100.0 
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Table 3. Changes in anthropometric parameters and hand- 
grip according to the response pattern. 
Variables n Median (IQR) p 
ALL participants    
MUAC (cm)    
Continous weight gain 83 2.4 (1.2 to 3.8) 
Static weight 14 −0.2 (−0.7 to 0.8) 
Continous weight loss 57 −0.8 (−1.5 to 0.1) 
p < 0.001
BMI (kg/m2)    
Continous weight gain 83 1.7 (0.8 to 2.7) 
Static weight 14 0.0 (−0.2 to 0.0) 
Continous weight loss 57 −1.1 (−1.6 to −0.7) 
p < 0.001
Handgrip (kg)    
Continous weight gain 82 2.6 (−0.3 to 6.5) 
Static weight 13 −0.2 (−4.0 to 1.5) 
Continous weight loss 54 −2.4 (−4.5 to 0.4) 
p < 0.001
Supplemented for at least 
3 months 
   
MUAC (cm)    
Continous weight gain 59 3.2 (2.2 to 4.2) 
Static weight 6 0.5 (−1.2 to 1.7) 
Continous weight loss 29 −0.6 (−1.8 to 0.7) 
p < 0.001
BMI (kg/m2)    
Continous weight gain 59 2.3 (1.1 to 3.0) 
Static weight 6 −0.1 (−0.2 to 0.0) 
Continous weight loss 29 −1.2 (−1.7 to −0.7) 
p < 0.001
Handgrip (kg)    
Continous weight gain 59 5.1 (1.7 to 8.7) 
Static weight 6 −1.6 (−5.9 to 0.1) 
Continous weight loss 29 −2.2 (−5.0 to 0.4) 
p < 0.001
 
compared (Table 3). 
The increase in proportion of participants able to per- 
form all the activity of daily living increased from 18.3% 
(15/82) to 69.5% (57/82) for the WG group (MacNemar 
test p < 0.001) and from 13.9% (13/72) to 33.3% (24/72) 
for the combined SW and WL group (MacNemar test p = 
0.030). For self perception of health condition, the pro- 
portion of those judging their health condition to be fair 
to excellent increased significantly from 42.7% (35/82) 
to 89.0% (73/82) for the WG group (p < 0.001) while the 
increase that was from 43.7% (31/71) to 62.0% (44/71) 
was not statistically significant for the combined SW and 
WL group (p = 0.597). Overall, 38.5% (72/187) of study 
participants died. The mortality was 19.3% (16/83) for 
the WG group, 35.7% (5/14) for the SW group and 
47.4% (27/57) for the WL group (p = 0.002). Out of the 
33 for whom weight change profile could not be calcu- 
lated, 72.7% (24/33) died. Among the WG group, 49.4% 
(41/83) fulfilled the discharge criteria of MUAC  23 cm. 
Table 4 presents the parameters recorded at admission 
or during the supplementation phase associated with 
weight gain in bivariate and logistic regression analyses. 
Of note, being on HAART and adhering to the number of 
visits were significantly and independently associated 
with increased chances of nutritional status improvement 
while the occurrence of episodes of acute diarrhoea, and 
complaint of poor appetite during supplementation nega- 
tively affected weight change.  
As shown on Figure 1, the percentage of patients be- 
longing to the WG varied according to the number of risk 
factors (not yet on HAART, acute diarrhoea during fol- 
low up, episode of reduced appetite during follow up, 
missing at least one visit). All participants who did not 
have any of the risk factors gained weight while only 
14.3% of those with all the risk factors were classified as 
belonging to WG pattern group (p < 0.001). The mean 
(SD) weight gain was 6.1 (2.9) kg for those without any 
of the risk factor, 3.9 (5.2) kg in presence of 1 risk factor, 
1.4 (4.9) kg in presence of 2 risk factors, −0.8 (3.5) kg in 
presence of 3 risk factors and −2.1 (2.9) kg in presence of 
4 risk factors. 
4. Discussion 
The protocol for the management of wasting in HIV in- 
dividuals from household from food insecure settings is 
yet to be established [32,38-40]. This situation is blamed 
on the absence of evidence that can help developing 
sound guidelines [32,41]. The present study has contrib.- 
uted on the development of the evidence by demonstrat- 
ing that wasting in PLHIV living in a context of wide- 
spread household food insecurity can be effectively re- 
versed with fortified energy dense food such us CS- 
RUTF and that the effectiveness may be enhanced when 
the supplementation is integrated to other therapeutic 
intervention including HAART and appropriate treatment 
of underlying opportunistic infection. 
Wasting remains an important comorbidity in AIDS 
patients in populations with as it is associated with in- 
creased mortality and its frequency remains high [11, 
12,21,27,31,34]. A recent large study that evaluated the 
prevalence among patient starting HAART in Lusaka 
found that 17% of the 40,788 registered during the study      
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Table 4. Admission characteristics associated with weight gain pattern. 
Unadjusted OR Adjusted OR 
Variable n % gained weight 
OR (95% CI) p OR (95% CI) p 
Model for admission parameters       
ART status       
Commenced prior to enrollment 39 76.9 4.0 (1.6 - 10.0) <0.001 2.7 (1.0 - 7.1) 0.042 
Not commenced at enrollement 112 45.5 1.0  1.0  
Oral diseases       
Present 15 26.7 0.3 (0.1 - 1.0) 0.028 0.3 (0.1 - 1.1) 0.066 
Absent 136 56.6 1.0  1.0  
HIV testing status       
Tested at enrollment 85 62.4 2.2 (0.9 - 4.3) 0.015 1.6 (0.7 - 3.5) 0.230 
Not tested at enrollment 66 42.4 1.0  1.0  
Gender       
Male 46 65.2 2.0 (0.9 - 4.3) 0.059 0.6 (0.3 - 1.3) 0.222 
Female 105 48.6 1.0  1.0  
Model for incident events       
ART status       
Commenced† 50 70.0 2.8 (1.3 - 6.8) 0005 3.6 (1.6 - 8.1) 0.002 
Not commenced 101 45.5 1.0  1.0  
Missed visits       
None 66 65.2 2.3 (1.3 - 4.7) 0.012 2.5 (1.2 - 5.3) 0.014 
>=1 85 44.7 1.0  1.0  
Complaint of reduced appetite       
At least once during follow up 57 36.8 0.3 (0.2 - 0.7) 0.001 0.4 (0.2 - 0.9) 0.024 
No complaint 94 63.2 1.0  1.0  
New episode of acute diarrhea       
At least once during follow up 48 43.8 0.6 (0.3 - 1.2) 0.096 0.4 (0.2 - 0.9) 0.036 
None 94 58.3 1.0  1.0  
New episode of fever       
At least once during follow up 57 36.8 0.4 (0.2 - 0.9) 0.017 0.5 (0.2 - 1.1) 0.087 
None 94 63.2 1.0  1.0  
Combined model       
ART status       
Commenced† 50 70.0 2.8 (1.3 - 6.8) 0.005 3.4 (1.5 - 7.8) 0.003 
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Not commenced 101 45.5 1.0  1.0  
Missed visits       
None 66 65.2 2.3 (1.3 - 4.7) 0.012 2.5 (1.2 - 5.3) 0.016 
>=1 85 44.7 1.0  1.0  
Complaint of reduced appetite       
At least once during follow up 57 36.8 0.3 (0.2 - 0.7) 0.001 0.4 (0.2 - 0.9) 0.028 
No complaint 94 63.2 1.0  1.0  
New episode of acute diarrhea       
At least once during follow up 48 43.8 0.6 (0.3 - 1.2) 0.096 0.4 (0.2 - 1.0) 0.053 
None 94 58.3 1.0  1.0  
New episode of fever       
At least once during follow up 57 36.8 0.4 (0.2 - 0.9) 0.017 0.6 (0.2 - 1.2) 0.126 
None 94 63.2 1.0  1.0  
Oral disease at admission       
Yes 15 26.7 0.3 (0.1 - 1.0) 0.027 0.6(0.2 - 2.2) 0.370 
No 136 53.6 1.0  1.0  
Not retained: peristent fever, persistent diarrhea, severe cough, hemoglobin level, CD4 count, Karnofsky score, handgrip, self perception of health condition, 
working status, walking status, marital status, food security condition, headache, BMI of admiss. 
 
 
Figure 1. Percentage of participant with nutrition status improvement according to number of independent risk factors.    
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period had a BMI < 17 kg/m2 and the figure was 34% if 
the cutoff of 18.5 kg/m2 was used [31]. In addition, 
evaluation of various HAART programmes have demon- 
strated that the presence of wasting at the time of com- 
mencing HAART, increases, by up to 6 times, the early 
(3-month) mortality [12,21,27]. The present study that 
was conducted at the start of the scale up of free HAART 
confirms that wasting is likely to remain common at the 
time of diagnosing HIV as most of the HIV infected 
wasted individuals enrolled into the study were not yet 
tested. Thus, for Malawi and most resource-poor coun- 
tries wasting in PLHIV remains an important public 
health problem given the contribution of this pandemic to 
the overall mortality of young adults [42].  
Given the public health importance of wasting of 
PLHIV, it is essential for countries affected by the HIV 
pandemic to identify an effective intervention that can 
reverse the wasting process while improving the quality 
of life of PLHIV. Several studies have now shown that 
therapeutic feeding with RUTF is a promising interven- 
tion [32,34-37]. A pilot study that included 60 HIV 
wasted adults already demonstrated the acceptability and 
tolerance of CS-RUTF used in the present study [36]. 
The pilot study also demonstrated a clear link between 
the amount of CS-RUTF intake and weight gain [36]. In 
a cohort of wasted individuals staring HAART in Malawi, 
supplementary feeding with RUTF was associated with 
higher weight gain than supplementary feeding with por- 
ridge made from a corn soya fortified blended floor [34]. 
Several findings of the present study confirm the CS- 
RUTF effectiveness. Despite the overall low weight gain 
observed in the present study and the low recovery rate, 
the fact that adherence to the programme doubled the 
chances of gaining weight, the impressive weight gain of 
6 kg when there were no detrimental risk factor, the 
higher increase in proportion of those with normal 
physical activity performance and those rating their 
health condition as fair to excellent among the WG pat- 
tern group when compared to the other groups, strongly 
suggest that the intervention was effective. 
The results of the present study showing that some of 
the patients had static weight or continued to loose 
weight despite good intake of CS-RUTF don’t have to be 
interpreted as an indication of ineffective therapeutic 
feeding. The apparently poor response was rather the 
consequence of the chronic inflammatory process that 
can be controlled by the adjunction of HAART as sug- 
gested by the strong independent relationship between 
HAART and the response pattern. It also outlines the fact 
that these patients usually present other comorbidity that 
interfere with nutrition recovery such us diarrhoea and 
oral candidiasis. HIV infection and many other chronic 
infections contribute to the development of wasting 
through an inflammatory process leading to cachexia and 
authors have observed that a food based intervention 
alone cannot reverse the cachexia process [43]. Thus, the 
judgment on the effectiveness of a therapeutic feeding 
intervention in PLHIV should take into account the qual- 
ity of the management of HIV itself and of the other co- 
morbidities.  
The detrimental effect on the response to therapeutic 
feeding interventions targeting PLHIV of factors identi- 
fied in this study namely absence of HAART, diarrhoea 
and oral disease have been reported before [44-47]. In 
study carried out in the pre-HAART era, Howard et al. 
obtained 8% recovery rate with home parenteral nutrition 
after 12 months in studies conducted in north America 
and Europe [48]. For diarrhoea, Beaugerie et al found a 
direct interrelation between the clinical severity of diar- 
rhoea and malnutrition in PLHIV, Carbonnel et al. noted 
that most HIV adults with weight loss of a cohort of 66 
individuals had diarrhoea associated with malabsorption 
and Stack et al showed that weight loss in wasted HIV 
infected individuals with diarrhoea can occur despite a 
good intake of therapeutic food [44,46,49]. In regards of 
our findings and that of the literature cited, severe wast- 
ing should be considered as an independent criterion for 
initiating HAART. Interestingly, the WHO staging crite- 
ria currently include moderate involuntary weight loss 
(<10%) as a stage 3 condition and severe involuntary 
weight loss (>10%) as a stage 4 condition. Unfortunately, 
these criteria are not practical as in many resource-poor 
countries premorbid weight is unknown. Consequently, 
the level of wasting is not always used for initiating 
HAART. Thus, we suggest the replacement of the weight 
loss criteria by criteria based on anthropometric meas- 
urement as already suggested by other authors [50,51].  
The high mortality rate of 38.5% observed in the pre- 
sent study has to be interpreted taking into account the 
fact that most of people enrolled were very sick. Almost 
half of them rated their health condition at admission as 
poor or very poor, a quarter was bedridden and unable to 
care for self and a third of the deaths occurred among 
those for whom we could not calculate weight change 
because the death occurred within 2 weeks of admission 
before the second visit. Also, only 25.7% of them have 
started HAART at the time of admission. However, the 
mortality we observed is not very much higher than the 
3.5-month mortality of 27% reported by Ndekha et al. 
among wasted individuals treated at the teaching hospital 
of Malawi for whom nutritional therapy was instituted at 
the same time with HAART [34]. A similar high mortal- 
ity of up to 88% was reported for small cohorts of AIDS 
patients on home parenteral nutrition in industrialized 
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countries during the pre-HAART era [52-57]. This situa- 
tion suggests that further reduction of the mortality of 
wasted PLHIV will probably depends in addition to early 
HAART initiation and effective therapeutic feeding, on 
the capacity of HAART programmes to diagnose and 
treat specific life threatening opportunistic infections.  
5. Conclusions 
In conclusion, despite some methodological limitations 
including the observational design of the study that pre- 
vent us from confidently attributing the observed effect 
to this intervention only, the limited number of partici- 
pants that prevented some sub-analyses, the use of self- 
reported intake to estimate intake that may have resulted 
in overestimation of intake and adherence, the present 
study suggest that supplementation with CS-RUTF is an 
effective intervention for reversing wasting in PLHIV but 
has limited impact on mortality. Its effectiveness is likely 
to be improved by concomitant initiation of HAART and 
specific treatment of severe opportunistic infection. Thus, 
we recommend the use of CS-RUTF or other similar 
products for the management of wasting of PLHIV. In 
patients not yet on HAART, this intervention should not 
delay HAART initiation but should be used to enable and 
faster initiate HAART. 
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